Trials / Unknown
UnknownNCT02942680
Efficacy and Safety of Aspirin Therapy With CABG
A Prospective Randomized Study of the Efficacy and Safety of Aspirin Therapy With CABG
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 350 (estimated)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
evaluate the safety of preoperative aspirin therapy when performing bypass surgery in conditions of artificial blood circulation
Detailed description
The hypothesis of the study was that aspirin therapy started 24 hours before CABG is safe. The effectiveness of this hypothesis will be assessed by the presence of a 30-day period after CABG myocardial infarction, ischemic stroke, repeat revascularizations
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | acetylsalicylic acid started for 24 hours before surgery | |
| DRUG | acetylsalicylic acid stayed for 5 days before surgery |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2016-10-24
- Last updated
- 2016-10-24
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT02942680. Inclusion in this directory is not an endorsement.